Identifying critical factors expressed specifically in liver tumor-initiating/propagating CD133 + , but not in CD133+ cells of the regenerating liver, may offer important therapeutic opportunities for overcoming chemoresistance in HCC. Here, PROM1 is linked to hepatocellular carcinoma.